Search Results - Hannah Verma

Online Patient Attitudes Toward Cutaneous Immune-Related Adverse Events Attributed to Nivolumab and Pembrolizumab: Sentiment Analysis by Camille M Powers, Andrew K Yang, Hannah Verma, Jeremy Orloff, Austin J Piontkowski, Nicholas Gulati

Connect to this object online.

Characterizing the readability of patient educational materials for melasma during pregnancy by Hannah Verma, BA, Samir Kamat, MD, Ross O'Hagan, MD, Susan Khalil, MD, Jenny Murase, MD

Connect to this object online.

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report by Camille M. Powers, Hannah Verma, Jeremy Orloff, Austin J. Piontkowski, Amy Tiersten, Angela Lamb, Nicholas Gulati

Connect to this object online.

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study by Jade N. Young, BS, Hannah Verma, BA, Nour El Kashlan, MD, Dina Poplausky, BA, Angela J. Lamb, MD, Emma Guttman-Yassky, MD, PhD, Nicholas Gulati, MD, PhD

Connect to this object online.